Úsek pro vědu a výzkum

Professional Publications

Author
Title
Year of publication

Publications (3663)

[521]

Zavadil, J.; Březinová, J.; Svoboda, P.; Zemanová, Z.; Michalová, K.

Smad 5, a tumor suppresor candidate at 5q31.1, is hemizygously lost and not mutated in the retained allele in human leukemia cell line HL60

[year of publication 2006, impact factor 3.227]

[522]

Cmejlova, J.; Pospisilova, D.; Cmejla, R.

Transcription factor GATA-4 is not involved in Diamond-Blackfan anaemia

[year of publication 2006, impact factor 3.226]

[523]

Preuner, S.; Barna, A.; Frommlet, F.; Czurda, S.; Konstantin, B.; Alikian, M.; Machova Polakova, K.; Sacha, T.; Richter, J.; Lion, T.; Gabriel, C.

Quantitative analysis of mutant subclones in chronic myeloid leukemia: comparison of different methodological approaches

[year of publication 2016, impact factor 3.226 ]

[524]

Smetana, K.

Harris Busch : obituary

[year of publication 2008, impact factor 3.224]

[525]

Šmahel, M.; Pokorná, D.; Macková, J.; Vlasák, J.

Enhancement of immunogenicity of HPV16 E7 oncogene by fusion with E. coli b-glucuronidase

[year of publication 2006, impact factor 3.224]

[526]

Veselský, L.; Dostál, J.; Holáň, V.; Souček, J.; Železná, B.

Effect of boar seminal immunosuppressive fraction on B lymphocytes and on primary antibody response

[year of publication 2006, impact factor 3.222]

[527]

Smetana, K.; Klamová, H.; Pluskalová, M.; Stöckbauer, P.; Hrkal, Z.:

To the intranucleolar translocation of AgNORs in leukemic early granulocytic and plasmacytic precursors.

[year of publication 2006, impact factor 3.220]

[528]

Haškovec, C.; Ponzetto, C.; Polák, J.; Maritano, D.; Zemanová, Z.; Serra, A.; Michalová, K.; Klamová, H.; Čermák, J.; Saglio, G.

P230 BCR/ABL protein may be associated with an acute leukaemia phenotype

[year of publication 2006, impact factor 3.209]

[529]

Jonasova, A.; Neuwirtova, R.; Cermak, J.; Vozobulova, V.; Mocikova, K.; Siskova, M.; Hochova, I.

Cyclosporin A therapy in hypoplastic MDS patients and certain refractory anaemias without hypoplastic bone marrow

[year of publication 2008, impact factor 3.209]

[530]

Zemánková, K.; Pavelicová, K.; Pompeiano, A.; Mravcová, L.; Černý, M.; Bendíčková, K.; Hortová Kohoutková, M.; Dryahina, K.; Vaculovičová, M.; Frič, J.; et al.

Targeted volatolomics of human monocytes: comparison of 2D-GC/TOF-MS and 1D-GC/Orbitrap-MS methods

[year of publication 2021, impact factor 3.205 ]

[531]

Machová Poláková, K.; Polívková, V.; Rulcová, J.; Klamová, H.; Jurček, T.; Dvořáková, D.; Žáčková, D.; Pospíšil, Z.; Mayer, J.; Moravcová, J.

Constant BCR-ABL transcript level less than or equal 0.1% (IS) in patients with CML responding to imatinib with complete cytogenetic remission may indicate mutation analysis

[year of publication 2009, impact factor 3.198]

[532]

Broadfield, Z.J.; Hain, R.D.W.; Harrison, C.J.; Jalali, G.R.; McKinley, M.; Michalová, K.; Robinson, H.M.; Zemanová, Z.; Martineau, M.

Complex chromosomal abnormalities in utero, 5 years before leukaemia

[year of publication 2006, impact factor 3.195]

[533]

Štolbová, Š.; Bezdíčka, M.; Prohászka, Z.; Csuka, D.; Hrachovinová, I.; et al.

Molecular basis and outcomes of atypical haemolytic uraemic syndrome in Czech children

[year of publication 2020, impact factor 3.183 ]

[534]

Štolbová, Š.; Bezdíčka, M.; Seeman, T.; Prohászka, Z.; Csuka, D.; Hrachovinová, I.; et al.

Correction to: Molecular basis and outcomes of a typical haemolytic uraemic syndrome in Czech children (European Journal of Pediatrics, (2020), 179, 11, (1739-1750), 10.1007/s00431-020-03666-9

[year of publication 2022, impact factor 3.183 ]

[535]

Kutinová, L.; Ludvíková, V.; Němečková, Š.; Hainz, P.; Simonová, V.; Vonka, V.

Secondary vaccination with vaccinia virus recombinants : role of residual virulence of recombinants and immunogenicity of extrinsic antigens

[year of publication 2006, impact factor 3.173]

[536]

Salaj, P.; Ovesna, P.; Penka, M.; Hedner, U.

Analyses of recombinant activated factor VII treatments from clinical practice for rapid bleeding and acute pain control in haemophilia patients with inhibitors

[year of publication 2012, impact factor 3.170 ]

[537]

Moravcová, J.; Lukášová, M.; Starý, J.; Haškovec, C.

Simple competitive two-step RT-PCR assay to monitor minimal residual disease in CML patients after bone marrow transplantation

[year of publication 2006, impact factor 3.163]

[538]

Moravcová, J.; Muchová, S.; Kalbáčová, R.; Haškovec, C.

Single-tube quantitative RT-PCR for monitoring of the response to INF treatment in CML patients

[year of publication 2006, impact factor 3.163]

[539]

Polák, J.; Zemanová, Z.; Michalová, K.; Klamová, H.; Čermák, J.; Haškovec, C.

A new case of chronic myeloid leukemia (CML) in myeloid blast crisis with an atypical (b3/a3) junction of the BCR/ABL gene

[year of publication 2006, impact factor 3.163]

[540]

Zavadil, J.; Svoboda, P.; Liang, H.; Kottickal, L.V.; Nagarajan, L.

An antisense transcript to SMAD5 expressed in fetal and tumor tissues

[year of publication 2006, impact factor 3.161]